Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Prevention Research

Resveratrol down-regulates eEF1A2 expression by blocking Akt/PI3K signaling in human ovarian cancer PA-1 cells

Mee-Hyun Lee, Bu Young Choi and Young-Joon Surh
Mee-Hyun Lee
College of Pharmacy, Seoul National University, Seoul, Republic of Korea, C&C Research Labs, Hwasung City, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bu Young Choi
College of Pharmacy, Seoul National University, Seoul, Republic of Korea, C&C Research Labs, Hwasung City, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Young-Joon Surh
College of Pharmacy, Seoul National University, Seoul, Republic of Korea, C&C Research Labs, Hwasung City, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2007
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

Abstract

3372

The eukaryotic elongation factor 1A2 (eEF1A2), a subtype of eEF1A that is a key factor in the translational process of protein synthesis, promotes the transfer of animoacylated tRNAs to the A site of the ribosome. Recently, eEF1A2 has been shown to possess a oncogenic potential as it is over-expressed in ovarian cancer. Therefore, suppression of the inappropriate expression of eEF1A2 is considered to be a rational therapeutic and preventive strategy for the management of ovarian cancer. Resveratrol (3,4’,5-trihydroxy stilbene), a phytoalexin present in grapes, has been reported to possess antioxidant, anti-inflammatory, and anti-carcinogenic activities. In the present study, we examined the anti-proliferative effect of resveratrol in PA-1 human ovarian cancer cells, considering eEF1A2 as a potential molecular target. Treatment of PA-1 cells with insulin (10 μg/ml) or serum (1%) resulted in the marked induction of eEF1A2. Resveratrol inhibited the viability, growth and soft agar colony formation of PA-1 cells. Pretreatment of PA-1 cells with resveratrol (25 or 50 μM) suppressed insulin- or serum-induced expression of eEF1A2 at 12 h. eEF1A2 exerts an anti-apoptotic effect by down-regulating the caspase-3 activity. Resveratrol was found to activate caspase-3, thereby inducing apoptosis in eEF1A2 over-expressing PA-1 cells, suggesting that the induction of apoptosis by resveratrol in these cells is mediated, at least in part, via down-regulation of eEF1A2. To clarify upstream signaling events responsible for regulation of eEF1A2, we determined the relative levels of phosphorylation of 18 representative protein kinases by antibody arrays (Proteome ProfilerTM, R&D Systems). We found that insulin induced phosphorylation of Akt1(S473)/2(S474)/pan(S473,S474,S472) which was inhibited by resveratrol as well as by LY294002 (20 μM). The pharmacologic inhibition of Akt activation with LY294002 abrogated insulin-induced eEF1A2 upregulation. Taken together, these results suggest that oncogenic eEF1A2 upregulated via the Akt/PI3K pathway is a potential target for ovarian cancer chemoprevention or treatment with resveratrol.

Footnotes

  • 98th AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 67 (9 Supplement)
May 2007
Volume 67, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Resveratrol down-regulates eEF1A2 expression by blocking Akt/PI3K signaling in human ovarian cancer PA-1 cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Resveratrol down-regulates eEF1A2 expression by blocking Akt/PI3K signaling in human ovarian cancer PA-1 cells
Mee-Hyun Lee, Bu Young Choi and Young-Joon Surh
Cancer Res May 1 2007 (67) (9 Supplement) 3372;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Resveratrol down-regulates eEF1A2 expression by blocking Akt/PI3K signaling in human ovarian cancer PA-1 cells
Mee-Hyun Lee, Bu Young Choi and Young-Joon Surh
Cancer Res May 1 2007 (67) (9 Supplement) 3372;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Prevention Research

  • Abstract LB-174: Patient navigation in Appalachia: results from a survey of current practices
  • Abstract LB-170: A novel, nontoxic RXR agonist, UAB30, targets Fanconi anemia DNA repair pathway to act as potent cancer chemopreventive agent
  • Abstract LB-153: Lotus leaf and Cassia seed extracts, through activating Nrf2 pathway, suppress TPA-induced mouse skin cell transformation
Show more 3

Signal Transduction 2: Poster Presentations

  • Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells
  • Antiproliferative effects of Hypericum Perforatum L. extract involve induction of p21CIP1 and inhibition of Rb expression in human bladder cancer cells.
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement